DAPT-Score
Eine längere als 12-monatige duale Plättchenhemmung nach perkutaner Koronarintervention beugt Herzinfarkten vor, erhöht aber zugleich das Blutungsrisiko. Ein neu entwickelter klinischer Risikoscore – der DAPT-Score – soll bei der individualisierten Entscheidung helfen, welcher Patienten von dieser Therapie profitiert und welcher nicht.

DAPT has been added to MedCalX version 3.2
-
Anonymous commented
DAPTscore to see who needs longer than 12 mo dual antiplatelet therapy
-
Anonymous commented
-
Anonymous commented
Dapt score helps to determine if a patient will benefit from a prolonged use of dual anti-platelet therapy
-
Daniel Fosburgh MD commented
Will be standard of care
-
Anonymous commented
Outil pour déterminer les risques-bénéfices de la DAPT plus d'un an après un SCA.
-
Anonymous commented
Duration of dual antiplateled therapy
-
Anonymous commented
For the duration of dual antiplatelet therapy after intracorronary stenting.
-
Anonymous commented
DAPT score for the duration of dual antiplatelet therapy after intracoronary stenting.
-
Anonymous commented
Please add dapt score - helps guide management of who should have long term dapt after 1 year
-
Anonymous commented
Very important for cardiology/interventional cardiology
-
Adnan Khalif commented
May help clinicians decide who should and who should not be treated with extended Dual-anti platelet therapy by identifying patients for whom ischemic benefits outweighed bleeding risks, and patients for whom bleeding risks outweighed ischemic benefits.